On September 2022, 9, the "23 (2022nd) China Venture Capital Forum" was grandly held online in Nansha, Guangzhou, which is a large-scale forum jointly hosted by the Central Committee of China Democratic Construction Association, Guangdong Provincial Government, Guangzhou Municipal Government and Shenzhen Municipal Government, which has important influence in China's venture capital community.

In the theme forum B1~Medical Investment Session, Dr. Jia Junxin, Chairman of New Value Capital, served as the special chairman, and the heads of six well-known biomedical investment institutions discussed the investment status, dynamics, trends and future development in the field of biomedicine and biomedical health.

In order to pay tribute to the annual benchmark of the venture capital industry, praise the market role model of the venture capital industry, and promote the high-quality development of venture capital, China Venture Capital Research Institute relies on its profound research background and huge market research data for nearly 20 years, and through data analysis, performance evaluation, industry influence and other levels of strict screening, to create an authoritative, comprehensive and objective list in the industry - the annual list of China's venture capital industry and the Golden Investment Award List.

The 2022 China Venture Capital Industry Annual List • Golden Investment Award List - Mid-year List has been grandly announced, and two lists, the comprehensive list and the industry list, were selected respectively, covering 12 sub-lists, and comprehensively commended investment institutions that have made major breakthroughs and outstanding contributions and created social benefits in China's venture capital industry.

New Value Capital won the "Top 2022 Best Investment Institutions in China's Intelligent Manufacturing Field" at the 30 China Venture Capital Industry Annual Golden Investment Award